老年慢性肢体威胁性缺血(CLTI)的血管内治疗:聚焦衰弱、创面愈合与结局
研究纳入131例≥70岁接受腹股沟下血管内治疗的CLTI患者,随访2年,按临床衰弱量表分为CFS 1-5组与CFS 6-9组。CFS 6-9组技术成功率较低、大截肢与总死亡率较高,无截肢生存率在1年和2年分别为67.9%和55%,创面愈合率76.1%,生活质量显著改善。
要点
- CFS 6-9组技术成功率80.8%,低于CFS 1-5组的93.1%。
- 大截肢率9.2%,CFS 6-9组单变量风险比5.20(P=0.033)。
- 1年无截肢生存率67.9%,2年55%,CFS 1-5组更高。
核心结论
- 高危CLTI患者成功的血管内治疗可促进创面愈合和改善治疗后生活质量。
- 血管内干预前应评估衰弱,因其与截肢和死亡等不良结局相关。
- 作者建议对较衰弱患者谨慎处理,强调老年CLTI患者个体化治疗。
研究设计与样本
- 研究纳入131例年龄≥70岁的CLTI患者,于2018年4月至2021年8月期间接受腹股沟下血管内干预,随访2年。
- 按临床衰弱量表(CFS)分为1组(CFS 1-5)和2组(CFS 6-9)。
- 93.9%患者有糖尿病,82.4%有高血压。
主要发现
- 技术成功率为86.3%,2组为80.8%,低于1组的93.1%。
- 大截肢率为9.2%,2组单变量风险比5.20(P=0.033)。
- 2组总死亡率单变量风险比5.18(P<0.001)。
- 1年和2年无截肢生存率分别为67.9%和55%,1组更高。
- 创面愈合率为76.1%(83/109),衰弱与创面愈合延迟显著相关(P<0.001);1年血管通畅率为88.8%。
关键数值与推荐
- 血管生活质量问卷-6(VascuQol-6)评分从基线平均9/24提高至2年时20/24。
- 衰弱评分与1年和2年VascuQol-6评分显著相关(P<0.0012)。
- 1组VascuQol-6评分高于2组,随访期间健康相关生活质量改善更明显。
临床怎么用
- 作者认为血管内干预前应评估衰弱,因其与截肢和死亡等不良结局相关。
- 作者建议对较衰弱患者谨慎处理,强调个体化治疗。
- 原文未据此给出其他推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: In India, a significant scarcity of published data exists regarding chronic limb-threatening ischemia (CLTI) and its management, especially among the elderly population. CLTI, often accompanied by frailty poses a significant healthcare challenge. While endovascular interventions offer hope, there remains a dearth of outcome data for this age group. This study seeks to address this critical gap by investigating the impact of frailty on outcomes, emphasizing amputation-free survival (AFS), wound healing, and health-related quality of life (HRQoL). METHODS: Our study included 131 elderly CLTI patients aged ≥70 years who underwent infrainguinal endovascular interventions between April 2018 and August 2021, with a follow-up period of 2 years. Among the patients, 93.9% had diabetes mellitus and 82.4% had hypertension. Clinical frailty was assessed using the clinical frailty scale (CFS). Patients were categorized into group 1 (CFS 1-5) and group 2 (CFS 6-9). Primary outcomes were AFS, wound healing, HRQoL, and their association with frailty. Secondary outcomes included technical success, procedure-related complications, major adverse limb events, major adverse cardiac events, vessel patency, re-intervention rates, and mortality rates including periprocedural and overall mortality. RESULTS: Technical success was achieved in 86.3% of patients, with frailty significantly influencing this outcome. Group 2 exhibited reduced technical success (80.8%) compared to group 1 (93.1%). The major amputation rate was 9.2%, with higher rates in group 2 [univariate hazard ratio: 5.20; P = 0.033]. Similarly, group 2 showed elevated overall mortality [univariate hazard ratio: 5.18; P < 0.001]. AFS at 1 and 2 years were 67.9% and 55%, respectively, with higher rates in group 1. Wound healing was achieved in 76.1% of patients (83/109), with frailty significantly associated with delayed wound healing (P < 0.001). Vessel patency at 1 year was observed in 88.8% of patients. HRQoL significantly improved postintervention, with vascular quality of life questionnaire-6 (VascuQol-6) scores increasing from an average of 9 of 24 at baseline to 20 of 24 at 2 years. Frailty score significantly correlated with VascuQol-6 scores at 1 and 2 years (P < 0.0012). Group 1 exhibited higher VascuQol-6 scores than group 2, indicating improved HRQoL during follow-up. CONCLUSIONS: Successful endovascular treatments in high-risk CLTI patients promote improved wound healing and post-treatment quality of life. Frailty should be assessed before endovascular interventions as it correlates with adverse outcomes, including amputations and mortality. While revascularization holds promise, caution is advised for frailer patients, emphasizing the importance of personalized care and tailored treatments for elderly CLTI patients.
引用
- Rajan A, Sima RR, Natarajan S, et al. Endovascular Management of Chronic Limb-Threatening Ischemia (CLTI) in the Elderly: A Focus on Frailty, Wound Healing, and Outcomes. Ann Vasc Surg. 2024. PMID: 38815902. doi:10.1016/j.avsg.2024.03.014
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。